Landing Point Financial Group »

Apellis Pharmaceuticals shares owned by Landing Point Financial Group

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Landing Point Financial Group from 13F filings

Historical chart of Landing Point Financial Group investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Landing Point Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Landing Point Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $433k 11k 40.23

More positions owned by Landing Point Financial Group

Ishares Core S&p 500 Etf Etf (IVV)
Fidelity High Dividend Etf Etf (FDVV)
Ishares Aaa Clo Active Etf Etf (CLOA)
Ishares Ultra Short Duration Bond Active Etf Etf (ICSH)
Apple Stock (AAPL)
Fidelity Enhanced Small Cap Etf Etf (FESM)
Ishares Msci Eafe Value Etf Etf (EFV)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Ishares Msci Emerging Markets Etf Etf (EEM)
Ishares Broad Usd Investment Grade Corporate Bond Etf Etf (USIG)
Amazon Stock (AMZN)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)

View all positions for Landing Point Financial Group

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals